Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444743
Status:
COMPLETED
Last Update Posted:
2008-12-18
First Post:
2007-03-07
Brief Title:
Phase 2 Study of MM-093 to Treat Patients With Uveitis
Sponsor:
Merrimack Pharmaceuticals
Organization:
Merrimack Pharmaceuticals
Organization Data
Organization:
Merrimack Pharmaceuticals
Class:
INDUSTRY
Study ID:
MM-093-03-200
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merrimack Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
Merrimack Pharmaceuticals